Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
Active, not recruiting · NCT05408546 · Registry updated 2026-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial | Embolism, Embolism and Thrombosis, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, vascular disorder | Active, not recruiting | Phase 2 | 2026-07-01 | NCT05408546 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Translational Sciences, Inc. | 2 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Banner University Medical Center | Phoenix | United States | 1 |
| Banner University Medical Center - Tucson | Tucson | United States | 1 |
| Cedars Sinai Medical Center | Los Angeles | United States | 135 |
| Cleveland Clinic | Cleveland | United States | 558 |
| Cottage Hospital | Santa Barbara | United States | 1 |
| Fairview Hospital | Cleveland | United States | 9 |
| Henry Ford Hospital | Detroit | United States | 1 |
| LifeBridge Health | Baltimore | United States | 4 |
| Temple University Hospital | Philadelphia | United States | 97 |
| Texas Tech University Health Sciences Center at El Paso | El Paso | United States | 1 |
| Tuft University Hospital | Boston | United States | 1 |
| Wake Forest University/Atrium Health's Carolinas Medical Center | Winston-Salem | United States | 1 |
| Wellstar MCG Health Medical Center | Augusta | United States | 2 |